Guardant Health (GH) Free Cash Flow (2017 - 2026)

Guardant Health has reported Free Cash Flow for 10 years, with the latest figure at -$69.5 million in Q2 2026.

• Quarterly Free Cash Flow fell 5.46% year-over-year to -$69.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$240.7 million (up 11.41% YoY) and the FY2025 annual result came in at -$233.1 million, up 15.23% from the prior year.
• Free Cash Flow rose to -$69.5 million in Q2 2026 per GH's latest filing, from -$71.2 million in the prior quarter.
• Over five years, Free Cash Flow peaked at -$37.2 million in Q1 2024 and troughed at -$135.0 million in Q2 2022.
• A 5-year average of -$76.7 million and a median of -$75.7 million in 2023 frame the typical range for Free Cash Flow.
• The sharpest annual moves came in 2022 and 2024: Free Cash Flow tumbled 98.32% in 2022, then soared 54.86% in 2024.
• Over 5 years, Free Cash Flow stood at -$100.8 million in 2022, then climbed by 17.81% to -$82.8 million in 2023, then retreated by 0.7% to -$83.4 million in 2024, then surged by 34.98% to -$54.2 million in 2025, then decreased by 28.25% to -$69.5 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$69.5 million, -$71.2 million, and -$54.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.